BRAF and neoplasm: The percentage of stage III/IV cutaneous tumours that were BRAF tested was 52% (n = 4558/8731), whereas the percentage of stage II and I tumours tested was 26% (n = 4441/16 844) and 3% (n = 1366/52 353), respectively.